A Multicentre Controlled Open Randomized Clinical Trial to evaluate the efficacy and safety profile of an anti-TB drug combination based on High Dose Rifampicin, High Dose Moxifloxacin and Linezolid daily for DS AFB smear positive pulmonary TB patients during the initial 8 weeks of treatment.
